Amoeba Aktie

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Amoeba Aktie had revenue of €63k and net profit of -€7.4m

(EUR)	June 2026	YoY
Revenue	63k	-
Gross profit	-3.34m	-
Net profit	-7.4m	-
EBITDA	-6.18m	-

Fundamentals

Metric	Value
Market capitalization	€19.91m
Number of shares	77.78m
52-week high/low	€1.12 - €0.25
Dividends	No
Beta	0.21
P/E ratio	-1.83
PEG ratio	82,351,536,043,346.20
P/B ratio	-3.72
P/S ratio	316.07

Company profile

Amoéba S.A. develops and sells biocidal and fungicide products. It is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds, and plant protection. The company was founded in 2010 and is headquartered in Chassieu, France.